Patents for C40B 30 - Methods of screening libraries (11,320) |
---|
11/17/2011 | US20110281750 Identifying High Risk Clinically Isolated Syndrome Patients |
11/17/2011 | US20110281749 Human t2r receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators |
11/17/2011 | US20110281748 Drug selection for gastric cancer therapy using antibody-based arrays |
11/17/2011 | US20110281747 Biomarkers for predicting rapid response to hcv treatment |
11/17/2011 | US20110281746 Methods and compositions related to quantitative, array based methylation analysis |
11/17/2011 | US20110281745 Screening assays and methods |
11/17/2011 | US20110281744 Method of identifying compounds that modulate regulation of iron response elements |
11/17/2011 | US20110281743 Systems and methods for isolating cells in cell colonies in culture |
11/17/2011 | US20110281742 Method for identifying electrophiles and nucleophiles in a sample |
11/17/2011 | US20110281741 Method and Apparatus for Rapid Nucleic Acid Sequencing |
11/17/2011 | US20110281740 Methods for Real Time Single Molecule Sequencing |
11/17/2011 | US20110281738 Self-assembled single molecule arrays and uses thereof |
11/17/2011 | US20110280886 Treating cancer by modulating mnk |
11/17/2011 | US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof |
11/17/2011 | US20110280863 Methods and compositions for the detection and treatment of preeclampsia |
11/17/2011 | US20110280813 Neuraminidase inhibitors and uses thereof |
11/17/2011 | CA2799416A1 Compositions and methods for targeting a3g:rna complexes |
11/17/2011 | CA2799165A1 Diagnostic markers for neuropsychiatric disease |
11/16/2011 | CN102242194A Method for screening microsatellite libraries |
11/16/2011 | CN101429234B Vaccine based on simulating human blood vessel endothelial cell growth factor VEGF epitope and preparation method thereof |
11/15/2011 | US8058072 Microanalysis measuring apparatus and microanalysis measuring method using the same |
11/15/2011 | US8058022 Diagnosis and monitoring of mycobacterium tuberculosis infection |
11/15/2011 | CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
11/10/2011 | WO2011139955A2 Multi-targeted priming for genome-wide gene expression assays |
11/10/2011 | WO2011139651A2 Detection of johnsongrass and its hybrid seed |
11/10/2011 | US20110277183 Alteration of plant architecture characteristics in plants |
11/10/2011 | US20110277045 Methods for increasing beta cell mass comprising administering a ra770 polypeptide |
11/10/2011 | US20110275558 Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders |
11/10/2011 | US20110275539 Substrate for selecting and specifically influencing the function of cells |
11/10/2011 | US20110275538 Measurement of biological targets |
11/10/2011 | US20110275537 Method of biological and medical diagnostics using immune patterns obtained with arrays of peptide probes |
11/10/2011 | US20110275536 Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
11/10/2011 | US20110275535 Yeast Display Systems |
11/10/2011 | US20110275534 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform |
11/10/2011 | US20110275533 Micro-RNAs as Markers for Tumor Progression |
11/10/2011 | US20110275532 Use of non-nucleophilic additives for reduction of surface morphological anomalies in probe arrays |
11/10/2011 | US20110275531 Method for the urinary detection of bladder cancer |
11/10/2011 | US20110275530 Methods and compositions for the diagnosis and treatment of epithelial cancers |
11/10/2011 | US20110275529 Identification and characterisation of recombinant viral gene therapy vectors |
11/10/2011 | US20110275528 Marker sequences for inflammatory prostate diseases, prostate carcinoma and their use |
11/10/2011 | US20110275527 Predictive Toxicology for Biological Systems |
11/10/2011 | US20110275526 Glycosyl transferase from chinese hamster and related methods |
11/10/2011 | US20110275525 Human Intestinal Normal Bacterial Flora DNA Chip and Method for Estimating Harmness to Human Body Due to Change of Human Intestinal Normal Bacterial Flora Using DNA Chip |
11/10/2011 | US20110275524 Methods and systems to detect an active protease in a sample |
11/10/2011 | US20110275058 Self-contained biological assay apparatus, methods, and applications |
11/10/2011 | US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses |
11/09/2011 | EP2385067A1 Artificial antibody polypeptides |
11/03/2011 | WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses |
11/03/2011 | US20110271357 Colon disease targets and uses thereof |
11/03/2011 | US20110271356 Hcv entry factor, occludin |
11/03/2011 | US20110269852 Methods and mechanisms involving hyperpigmentation particularly for african american skin |
11/03/2011 | US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
11/03/2011 | US20110269644 Structures for enhanced detection of fluorescence |
11/03/2011 | US20110269643 Mass spectrometric methods for detecting mutations in a target nucleic acid |
11/03/2011 | US20110269642 Modular assay plates, reader systems and methods for test measurements |
11/03/2011 | US20110269641 Methods and systems for controlling liquids in multiplex assays |
11/03/2011 | US20110269640 PROBES FOR DETECTING MUTATIONS OF kRas GENE, LIQUICHIP AND DETECTION METHODS THEREOF |
11/03/2011 | US20110269639 Detection of Johnsongrass and Its Hybrid Seed |
11/03/2011 | US20110269638 Genes associated with post relapse survival and uses thereof |
11/03/2011 | US20110269637 Method for Predicting Clinical Outcome of Patients With Non-Small Cell Lung Carcinoma |
11/03/2011 | US20110269636 Materials and methods for identifying patients at heighten risk for developing her2+ related brain tumors |
11/03/2011 | US20110269635 Systems and methods for high-throughput screening using light scattering |
11/03/2011 | US20110269634 Methods and Compositions for Risk Stratification |
11/03/2011 | US20110269633 Inflammatory biomarkers for monitoring depressive disorders |
11/03/2011 | US20110269632 Detection of Cancer through Breath Comprising a Sensor Array Comprising Capped Conductive Nanoparticles |
11/03/2011 | US20110269631 Amplification and Analysis of Selected Targets on Solid Supports |
11/03/2011 | US20110267457 Systems and methods for nucleic acid sequencing |
11/01/2011 | CA2400338C A molecular library for recognition or detection of a binding site |
10/27/2011 | WO2011133748A1 Treatments for cellular proliferative disorders and identification thereof |
10/27/2011 | WO2011132940A2 Rtk-bpb specifically binding to rtk |
10/27/2011 | WO2011132939A2 Rtk-bpb specifically binding to rtk |
10/27/2011 | WO2011132938A2 Gpcr-bpb specifically binding to gpcr |
10/27/2011 | WO2011132175A2 Novel biomarkers and targets for ovarian carcinoma |
10/27/2011 | US20110265221 Transgenic plants with enhanced agronomic traits |
10/27/2011 | US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof |
10/27/2011 | US20110263821 Prognosis and risk assessment in stroke patients by determining the level of marker peptides |
10/27/2011 | US20110263688 Coferons and methods of making and using them |
10/27/2011 | US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity |
10/27/2011 | US20110263455 Optical system for multiple reactions |
10/27/2011 | US20110263454 Methods of Identifying Functional Characteristics of Promoters, Transcription Modifying Proteins and Transcription Modulating Agents |
10/27/2011 | US20110263453 Nucleic acid quantification products and processes |
10/27/2011 | US20110263452 Platelet analysis |
10/27/2011 | US20110263451 Biological markers predictive of rheumatoid arthritis response to lymphotoxin antagonists |
10/27/2011 | US20110263450 Alzheimer's disease biomarkers |
10/27/2011 | US20110263449 In vitro method and kit for prognosis or prediction of response by patients with rheumatoid arthritis to treatment with tnf-alpha factor blocking agents |
10/27/2011 | US20110263448 Interferon Response in Clinical Samples (IRIS) |
10/27/2011 | US20110263447 Method for the prognosis and diagnosis of type ii diabetes in critical persons |
10/27/2011 | US20110263446 Kit useful for detecting, separating and/or characterizing a molecule of interest |
10/27/2011 | US20110263445 Multidentate Arrays |
10/27/2011 | US20110263444 Method for examining prognosis of breast cancer |
10/27/2011 | US20110263443 Differentiating between fibrosis and cirrhosis |
10/27/2011 | US20110263442 Method of using biomarkers |
10/27/2011 | US20110263441 Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders |
10/27/2011 | US20110263440 Colorimetric bioassay for perchlorate |
10/27/2011 | US20110263439 Markers associated with alzheimer's disease |
10/27/2011 | US20110263438 Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin |
10/27/2011 | US20110263437 Analysis of Y-Chromosome STR Markers |
10/27/2011 | US20110262570 Transcriptional Profiling and Biomarker-Based Methods for Identifying and Evaluating Agents for Antioxidant Efficacy in Cosmetic Skin Care Formulations |
10/27/2011 | US20110262463 Syngr4 for target genes of cancer therapy and diagnosis |
10/27/2011 | US20110262426 Methods and kits used in identifying glioblastoma |